Beacon Trusteeship Regulatory Approval

Employee Stock Options

Beacon Trusteeship Employee Stock Options

Beacon Trusteeship Limited has granted 50,500 Employee Stock Options to eligible employees under the BTL ESOP Plan 2025.

Other Announcement

Beacon Trusteeship Other Announcement

Beacon Trusteeship Limited informed the exchange that Corporate Governance provisions are not applicable to the company for the quarter ended September 30, 2026.

Regulatory ApprovalAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Beacon Trusteeship Regulatory Approval

Beacon Trusteeship's subsidiary, Beacon Investor Holdings, received SEBI approval to operate as a trading member on the Metropolitan Stock Exchange (MSEIL).

Employee Stock Options

Beacon Trusteeship Employee Stock Options

Beacon Trusteeship Limited has allotted 28,000 equity shares under its ESOP Plan 2025. This allotment increases the company's total issued and subscribed share capital to 1,80,92,913 shares.

Value

₹0.17 Cr

Other Announcement

Beacon Trusteeship Other Announcement

Beacon Trusteeship Limited's board approved amending its Memorandum of Association to expand its business scope. This enables potential future entry into new financial services segments.

Merger & Restructuring

Beacon Trusteeship Merger & Restructuring Worth ₹0.25 Cr

Beacon Trusteeship Limited is incorporating a Wholly Owned Subsidiary in Dubai for financial services. The investment for this expansion is approximately INR 25 Lakhs (0.25 Crore).

Value

₹0.25 Cr

Regulatory ApprovalVedavaag Systems Ltd VEDAVAAG

Vedavaag Systems Regulatory Approval

Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.

Regulatory ApprovalHikal Ltd HIKALAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.

Regulatory ApprovalRNFI Services Ltd RNFIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.